These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 30396939)

  • 1. Suppression of Taxanes Cytotoxicity by Citrus Flavonoid Hesperetin in PPC-1 Human Prostate Cancer Cells.
    Sak K; Lust H; Kase M; Saar M; Jaal J
    Anticancer Res; 2018 Nov; 38(11):6209-6215. PubMed ID: 30396939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fisetin Enhances Chemotherapeutic Effect of Cabazitaxel against Human Prostate Cancer Cells.
    Mukhtar E; Adhami VM; Siddiqui IA; Verma AK; Mukhtar H
    Mol Cancer Ther; 2016 Dec; 15(12):2863-2874. PubMed ID: 27765854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of luteolin cytotoxicity by flavonols fisetin and quercetin in human chronic lymphocytic leukemia cell lines.
    Sak K; Kasemaa K; Everaus H
    Food Funct; 2016 Sep; 7(9):3815-24. PubMed ID: 27489195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices.
    So FV; Guthrie N; Chambers AF; Moussa M; Carroll KK
    Nutr Cancer; 1996; 26(2):167-81. PubMed ID: 8875554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pleiotropic effects of fisetin and hesperetin on human acute promyelocytic leukemia cells are mediated through apoptosis, cell cycle arrest, and alterations in signaling networks.
    Adan A; Baran Y
    Tumour Biol; 2015 Nov; 36(11):8973-84. PubMed ID: 26081618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulatory potential of hesperetin and chrysin through the cellular and humoral response.
    Sassi A; Mokdad Bzéouich I; Mustapha N; Maatouk M; Ghedira K; Chekir-Ghedira L
    Eur J Pharmacol; 2017 Oct; 812():91-96. PubMed ID: 28690190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical profile of cabazitaxel.
    Vrignaud P; Semiond D; Benning V; Beys E; Bouchard H; Gupta S
    Drug Des Devel Ther; 2014; 8():1851-67. PubMed ID: 25378905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical antitumor activity of cabazitaxel, a semisynthetic taxane active in taxane-resistant tumors.
    Vrignaud P; Sémiond D; Lejeune P; Bouchard H; Calvet L; Combeau C; Riou JF; Commerçon A; Lavelle F; Bissery MC
    Clin Cancer Res; 2013 Jun; 19(11):2973-83. PubMed ID: 23589177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploitation of the Androgen Receptor to Overcome Taxane Resistance in Advanced Prostate Cancer.
    Martin SK; Kyprianou N
    Adv Cancer Res; 2015; 127():123-58. PubMed ID: 26093899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of taxanes in advanced prostate cancer.
    Cassinello J; Carballido Rodríguez J; Antón Aparicio L
    Clin Transl Oncol; 2016 Oct; 18(10):972-80. PubMed ID: 26856599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transport and cytotoxicity of paclitaxel, docetaxel, and novel taxanes in human breast cancer cells.
    Ehrlichova M; Vaclavikova R; Ojima I; Pepe A; Kuznetsova LV; Chen J; Truksa J; Kovar J; Gut I
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Jul; 372(1):95-105. PubMed ID: 16059735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of DNA Methylation in Cabazitaxel Resistance in Prostate Cancer.
    Ramachandran K; Speer C; Nathanson L; Claros M; Singal R
    Anticancer Res; 2016 Jan; 36(1):161-8. PubMed ID: 26722040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cabazitaxel operates anti-metastatic and cytotoxic via apoptosis induction and stalls brain tumor angiogenesis.
    Ghoochani A; Hatipoglu Majernik G; Sehm T; Wach S; Buchfelder M; Taubert H; Eyupoglu IY; Savaskan N
    Oncotarget; 2016 Jun; 7(25):38306-38318. PubMed ID: 27203678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The apoptotic effect of hesperetin on human cervical cancer cells is mediated through cell cycle arrest, death receptor, and mitochondrial pathways.
    Alshatwi AA; Ramesh E; Periasamy VS; Subash-Babu P
    Fundam Clin Pharmacol; 2013 Dec; 27(6):581-92. PubMed ID: 22913657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propofol Reversed Hypoxia-Induced Docetaxel Resistance in Prostate Cancer Cells by Preventing Epithelial-Mesenchymal Transition by Inhibiting Hypoxia-Inducible Factor 1
    Qian J; Shen S; Chen W; Chen N
    Biomed Res Int; 2018; 2018():4174232. PubMed ID: 29568752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flavonoids, bioactive components of propolis, exhibit cytotoxic activity and induce cell cycle arrest and apoptosis in human breast cancer cells MDA-MB-231 and MCF-7 - a comparative study.
    Kabała-Dzik A; Rzepecka-Stojko A; Kubina R; Iriti M; Wojtyczka RD; Buszman E; Stojko J
    Cell Mol Biol (Noisy-le-grand); 2018 Jun; 64(8):1-10. PubMed ID: 29981677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A combination of desmopressin and docetaxel inhibit cell proliferation and invasion mediated by urokinase-type plasminogen activator (uPA) in human prostate cancer cells.
    Sasaki H; Klotz LH; Sugar LM; Kiss A; Venkateswaran V
    Biochem Biophys Res Commun; 2015 Aug; 464(3):848-54. PubMed ID: 26182875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between docetaxel resistance and castration resistance in prostate cancer: implications of Twist1, YB-1, and androgen receptor.
    Shiota M; Kashiwagi E; Yokomizo A; Takeuchi A; Dejima T; Song Y; Tatsugami K; Inokuchi J; Uchiumi T; Naito S
    Prostate; 2013 Sep; 73(12):1336-44. PubMed ID: 23775496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of taxanes on the management of genitourinary cancers.
    Balar AV
    Anticancer Drugs; 2014 May; 25(5):555-60. PubMed ID: 24525590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer.
    Li Y; Kucuk O; Hussain M; Abrams J; Cher ML; Sarkar FH
    Cancer Res; 2006 May; 66(9):4816-25. PubMed ID: 16651437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.